Sterling Hospitals · KD Hospital · Welcare Speciality Hospital, Ahmedabad Message on WhatsApp
Endometrial Cancer HIPEC

Early Endometrial Cancer Fertility-Sparing Treatment — Hormone Therapy Option

Early endometrial cancer fertility-sparing treatment with progesterone hormone therapy. Eligibility, surveillance. Dr. Nishtha Tripathi Patel.

Early Endometrial Cancer Fertility Sparing in Ahmedabad — Dr. Nishtha Tripathi Patel is an ESGO-certified gynaecological oncosurgeon offering specialist treatment for early endometrial cancer fertility sparing at Sterling Hospitals, KD Hospital and Welcare Speciality Hospital in Ahmedabad.

early endometrial cancer fertility sparing — Dr. Nishtha Tripathi Patel

On this page

Early endometrial cancer fertility sparing — What does this stage mean?

Selected young women with Stage 1A, grade 1 endometrioid endometrial cancer who wish to preserve fertility can be offered hormonal therapy (megestrol acetate or levonorgestrel-IUD) with strict surveillance. Hysteroscopic resection of focal lesions may be combined. Complete response rate is approximately 70% over 6-12 months.

For broader information see our cancer overview and treatment page.

Recommended treatment pathway

Selected young women with Stage 1A, grade 1 endometrioid endometrial cancer who wish to preserve fertility can be offered hormonal therapy (megestrol acetate or levonorgestrel-IUD) with strict surveillance. Hysteroscopic resection of focal lesions may be combined. Complete response rate is approximately 70% over 6-12 months.

Adjuvant therapy

Definitive hysterectomy is recommended after completing family or if response is not achieved within 12 months.

Outlook

Approximately 70% achieve complete response. Pregnancy rate after response is 25-35%. Recurrence rate during follow-up is significant (25-40%); ongoing surveillance is essential.

External authoritative reference: NCCN Guidelines and ESGO Recommendations.

Booking

For an individualised treatment plan, share your reports on WhatsApp (+91 76988 00333) or book an appointment. Second opinions are available for patients already under care elsewhere.

FAQs

Where is early endometrial cancer fertility sparing performed in Ahmedabad?

Dr. Nishtha Tripathi Patel treats this disease stage at Sterling Hospitals (Sindhubhavan), KD Hospital, and Welcare Speciality Hospital in Ahmedabad. The hospital is chosen based on the specific procedure needed and patient preference.

What is the typical hospital stay?

For minimally invasive surgery (robotic or laparoscopic), hospital stay is typically 3-4 days. For cytoreductive surgery or HIPEC, stay extends to 7-10 days. Chemoradiation is outpatient over 5-7 weeks.

What is the likely outcome?

Approximately 70% achieve complete response. Pregnancy rate after response is 25-35%. Recurrence rate during follow-up is significant (25-40%); ongoing surveillance is essential. Outcomes are stage-dependent and individual; the figures above are averages from published series.

Is fertility preservation possible?

For selected young women with Stage 1A grade 1 disease, hormonal management with strict surveillance is offered as an alternative to surgery — see our dedicated page.

Can I get a second opinion before deciding?

Yes. Share your reports on WhatsApp (+91 76988 00333). Dr. Nishtha provides independent review of stage, pathology, imaging and proposed treatment within 24-48 hours.

Consultation and Next Steps

For an individualised consultation on early endometrial cancer fertility sparing, share your reports on WhatsApp at +91 76988 00333. Dr. Nishtha Tripathi Patel provides a detailed assessment within 24-48 hours and arranges in-person consultation at Sterling Hospitals, KD Hospital, or Welcare Speciality Hospital in Ahmedabad based on your location and treatment requirements.

Bring the following to your first consultation: imaging studies (ultrasound, CT or MRI on CD), histopathology and biopsy reports, tumour marker results (CA-125, HE4, CEA where relevant), a list of current medications, and any prior treatment summaries. For patients travelling from outside Ahmedabad, scheduling can be arranged to complete consultation and any pre-op work-up in the fewest possible visits.

If you are exploring second-opinion options, see our second-opinion service page. Independent review of diagnosis, staging, and proposed treatment plans is provided at no cost via WhatsApp report review. You do not need to switch hospitals to obtain a second opinion.

For broader information about early endometrial cancer fertility sparing and related conditions, also see our complete ovarian cancer guide, HIPEC India guide, cervical cancer guide and robotic surgery guide.


Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified.

Need guidance on the next step in care?

7698800333 WhatsApp
Call Book